Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

O2h Ventures

Investor type Venture Capital
Founders Sunil Shah


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 20
Average round size
The average size of a deal this fund participated in
Portfolio companies 16
Lead investments 6
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Artificial Intelligence

O2h Ventures appeared to be the VC, which was created in 2003.

The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this O2h Ventures works on 15 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the O2h Ventures, startups are often financed by Innovate UK, Angel CoFund, Wellcome Trust. The meaningful sponsors for the fund in investment in the same round are Oxford Investment Opportunity Network, Esther Dyson, Delin Ventures. In the next rounds fund is usually obtained by Department of Health and Social Care (DHSC).

The fund was created by Sunil Shah.

The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Oxford Drug Design, Exonate. Among the most popular fund investment industries, there are Software, SaaS. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of O2h Ventures:
Typical Co-investors
O2h Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after O2h Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AGTech Holdings China, Hong Kong, Hong Kong Island
CIT Healthcare Finance -
Curious Office Partners Seattle, United States, Washington
Digital Base Capital Chiyoda, Japan
Enphase Energy California, Petaluma, United States
Ernst & Young England, London, United Kingdom
Hubei Dewo China, Fujian, Hubei
JYTH Beijing, Beijing, China
K-Svets Venture Sweden, Vastra Gotaland, Västra Götaland County
Leonardo Italy, Lazio, Roma
LINE Financial Corporation Chiyoda, Japan
Matmut France, Haute-Normandie, Rouen
Mavaconsult -
PPTV China, Shanghai
Riverbed Technology California, San Francisco, United States
Taaleri Finland, Helsinki, Southern Finland
TDM Partners China, Hong Kong, Hong Kong Island
Zhongshi Capital China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CardiaTec Biosciences

Life Science
$1M06 Jul 2022 Cambridge, Cambridgeshire, United Kingdom

Spirea Ltd.

Health Care
$3M14 Jun 2022 Cambridge, Cambridgeshire, United Kingdom

Oxford Drug Design

$3M19 May 2022 Oxford, England, United Kingdom


Health Care
$2M28 Sep 2021 London, England, United Kingdom


Artificial Intelligence
$1M08 Jul 2021 London, England, United Kingdom


$2M20 Apr 2021 Cambridge, England, United Kingdom


Health Care
$45M23 Mar 2021 Cambridge, England, United Kingdom

Spirea Ltd.

Health Care
22 Jan 2021 Cambridge, Cambridgeshire, United Kingdom


Artificial Intelligence
$6M07 Jan 2021 Budapest, Hungary
News Raises £1M in Seed Funding

–, a London, UK-based provider of a software platform for quantum modelling of enzymes, raised £1m in seed funding.
– Backers included ACF Investors, o2h Ventures and a syndicate of Cambridge-based angel investors.
– The company intends to use the funds to expand the technology team and further develop its platform and asset development, including its own range of novel therapeutics and creating a data bank for use in its work with academic and commercial partners.

PhoreMost Raises $46M in Series B Financing

– PhoreMost is a Cambridge, England, UK-based biopharmaceutical company.
– The company raised $46m in Series B funding.
– The round was led by BGF, and included new investor – XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures.
– Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent O2h Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: